ARZNEIWERK AG VIDA (TLIK.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:TLIK - DE000A289B07 - Common Stock
TLIK.DE Key Statistics, Chart & Performance
The current stock price of TLIK.DE is 0.585 EUR. In the past month the price decreased by -3.31%. In the past year, price decreased by -45.33%.
TLIK.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AXNA.DE | AMPLIFON SPA | 25.83 | 3.10B | ||
| AMP.MI | AMPLIFON SPA | 25.72 | 3.09B | ||
| FAGR.BR | FAGRON | 18.16 | 1.57B | ||
| UPR.I | UNIPHAR PLC | 15.77 | 900.71M | ||
| ILM1.DE | MEDIOS AG | 16.25 | 360.71M | ||
| BLC.PA | BASTIDE LE CONFORT MEDICAL | 336.43 | 173.56M | ||
| PRE.MI | PREDICT SPA | 13.92 | 4.65M | ||
| VMED.DE | VIROMED MEDICAL AG | N/A | 72.50M |
Related stock screener links
About TLIK.DE
Company Profile
Arzneiwerk AG VIDA engages in the provision of software development and maintenance of telecommunications solutions for service providers. The company is headquartered in Berlin, Berlin and currently employs 52 full-time employees. The company went IPO on 2007-11-14. The firm is active in the pharmaceutical segment, where it focuses on the growth area of Specialty Pharma in Germany and Europe. Specialty Pharma usually includes high-priced drugs for chronic, complex, or rare diseases. The company focuses on six indication areas: oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry.
Company Info
ARZNEIWERK AG VIDA
Ordensmeisterstr. 15-16
Berlin BERLIN DE
Employees: 39
Phone: 4930399280900
ARZNEIWERK AG VIDA / TLIK.DE FAQ
What does TLIK do?
Arzneiwerk AG VIDA engages in the provision of software development and maintenance of telecommunications solutions for service providers. The company is headquartered in Berlin, Berlin and currently employs 52 full-time employees. The company went IPO on 2007-11-14. The firm is active in the pharmaceutical segment, where it focuses on the growth area of Specialty Pharma in Germany and Europe. Specialty Pharma usually includes high-priced drugs for chronic, complex, or rare diseases. The company focuses on six indication areas: oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry.
What is the stock price of ARZNEIWERK AG VIDA today?
The current stock price of TLIK.DE is 0.585 EUR. The price increased by 17% in the last trading session.
Does TLIK stock pay dividends?
TLIK.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of TLIK stock?
TLIK.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
On which exchange is TLIK.DE stock listed?
TLIK.DE stock is listed on the Frankfurt Stock Exchange exchange.
What is the GICS sector and industry of TLIK stock?
ARZNEIWERK AG VIDA (TLIK.DE) operates in the Health Care sector and the Health Care Providers & Services industry.
Can you provide the ownership details for TLIK stock?
You can find the ownership structure of ARZNEIWERK AG VIDA (TLIK.DE) on the Ownership tab.
TLIK.DE Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to TLIK.DE. When comparing the yearly performance of all stocks, TLIK.DE is a bad performer in the overall market: 91.65% of all stocks are doing better.
TLIK.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to TLIK.DE. TLIK.DE has a bad profitability rating. Also its financial health evaluation is rather negative.
TLIK.DE Financial Highlights
Over the last trailing twelve months TLIK.DE reported a non-GAAP Earnings per Share(EPS) of -0.34. The EPS increased by 82.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -18.11% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |